| Secondary |
| Drug Use For Unknown Indication |
40.7% |
| Product Used For Unknown Indication |
13.1% |
| Hypertension |
8.3% |
| Prophylaxis |
6.9% |
| Breast Cancer |
3.4% |
| Deep Vein Thrombosis |
2.8% |
| Venous Stasis |
2.8% |
| Depression |
2.1% |
| Diabetes Mellitus |
2.1% |
| Diabetic Complication |
2.1% |
| Diabetic Neuropathy |
2.1% |
| Impaired Gastric Emptying |
2.1% |
| Lung Infection |
2.1% |
| Oedema |
2.1% |
| Dyslipidaemia |
1.4% |
| Haemorrhoids |
1.4% |
| Hypothyroidism |
1.4% |
| Osteoarthritis |
1.4% |
| Prostate Cancer |
1.4% |
| Acne |
0.7% |
|
| Urinary Tract Infection |
12.5% |
| Thrombocytopenia |
9.4% |
| Urinary Retention |
9.4% |
| Pemphigoid |
6.3% |
| Pruritus |
6.3% |
| Renal Tubular Disorder |
6.3% |
| Toxic Skin Eruption |
6.3% |
| Urticaria |
6.3% |
| Colitis Microscopic |
3.1% |
| Death |
3.1% |
| Dermatitis Bullous |
3.1% |
| Dermatitis Exfoliative |
3.1% |
| Gamma-glutamyltransferase Increased |
3.1% |
| Hyponatraemia |
3.1% |
| International Normalised Ratio Increased |
3.1% |
| Myalgia |
3.1% |
| Pancreatitis Acute |
3.1% |
| Peritoneal Disorder |
3.1% |
| Pregnancy |
3.1% |
| Purpura |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.0% |
| Hypertension |
14.2% |
| Drug Use For Unknown Indication |
12.0% |
| Osteoporosis |
6.9% |
| Pain |
5.7% |
| Prophylaxis |
5.2% |
| Rheumatoid Arthritis |
4.9% |
| Depression |
2.9% |
| Venous Insufficiency |
2.9% |
| Blood Cholesterol Increased |
2.3% |
| Hypercholesterolaemia |
2.2% |
| Arrhythmia |
2.1% |
| Insomnia |
2.1% |
| Type 2 Diabetes Mellitus |
2.1% |
| Vertigo |
1.9% |
| Diabetes Mellitus |
1.9% |
| Haemorrhoids |
1.8% |
| Varicose Vein |
1.8% |
| Breast Cancer |
1.7% |
| Anxiety |
1.6% |
|
| Pancreatitis |
10.2% |
| Thrombocytopenia |
7.5% |
| Renal Failure Acute |
6.8% |
| Thrombosis |
6.8% |
| Weight Increased |
6.8% |
| Renal Failure |
5.4% |
| Fall |
4.8% |
| Pruritus |
4.8% |
| Somnolence |
4.8% |
| Death |
4.1% |
| Myocardial Infarction |
4.1% |
| Pain In Extremity |
4.1% |
| Status Epilepticus |
4.1% |
| Toxic Skin Eruption |
4.1% |
| Urinary Tract Infection |
4.1% |
| Weight Decreased |
4.1% |
| Hypotension |
3.4% |
| Lipase Increased |
3.4% |
| Pulmonary Embolism |
3.4% |
| Pyrexia |
3.4% |
|
| Interacting |
| Chronic Myeloid Leukaemia |
100.0% |
|
|
